Neuroscientific Biopharmaceuticals (NSB) Short Interest
Neuroscientific Biopharmaceuticals (ASX:NSB) had 0.00% of shares reported as short positions as of 29 June 2026, representing 3,800 shares. Neuroscientific Biopharmaceuticals operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Neuroscientific Biopharmaceuticals
NeuroScientific Biopharmaceuticals Ltd is an Australian biotechnology company focused on developing novel stem cell technologies for immune-mediated inflammatory diseases. Their patented StemSmart™ technology aims to enhance the safety and efficacy of mesenchymal stem cell (MSC) therapies, targeting conditions like Crohn's disease. The company is currently prioritizing a special access program for fistulising Crohn’s disease and plans to advance to clinical trials.
Short position
Neuroscientific Biopharmaceuticals (ASX:NSB) has 0.00% of its shares on issue reported as short positions as of 29 June 2026, or about 3,800 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. NSB is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4NSB intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Neuroscientific Biopharmaceuticals
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss NSB
Start a research thread or post the first pulse update